CA2316269A1 - Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide - Google Patents

Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide Download PDF

Info

Publication number
CA2316269A1
CA2316269A1 CA002316269A CA2316269A CA2316269A1 CA 2316269 A1 CA2316269 A1 CA 2316269A1 CA 002316269 A CA002316269 A CA 002316269A CA 2316269 A CA2316269 A CA 2316269A CA 2316269 A1 CA2316269 A1 CA 2316269A1
Authority
CA
Canada
Prior art keywords
rheumatoid arthritis
antigen
peptide
autoantibodies
filaggrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002316269A
Other languages
English (en)
French (fr)
Inventor
Guy Serre
Elisabeth Girbal-Neuhauser
Christian Vincent
Michel Simon
Mireille Sebbag
Pascal Dalbon
Colette Jolivet-Reynaud
Michel Arnaud
Michel Jolivet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2316269A1 publication Critical patent/CA2316269A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Rehabilitation Therapy (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
CA002316269A 1997-12-30 1998-12-29 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide Abandoned CA2316269A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR97/16673 1997-12-30
FR9716673A FR2773157B1 (fr) 1997-12-30 1997-12-30 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
PCT/FR1998/002899 WO1999035167A1 (fr) 1997-12-30 1998-12-29 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide

Publications (1)

Publication Number Publication Date
CA2316269A1 true CA2316269A1 (fr) 1999-07-15

Family

ID=9515272

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002316269A Abandoned CA2316269A1 (fr) 1997-12-30 1998-12-29 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide

Country Status (5)

Country Link
EP (1) EP1042366A1 (de)
AU (1) AU1971799A (de)
CA (1) CA2316269A1 (de)
FR (1) FR2773157B1 (de)
WO (1) WO1999035167A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773078B1 (fr) * 1997-12-30 2000-05-26 Univ Toulouse Utilisation de peptides citrullines derives de la filaggrine pour le traitement de la polyarthrite rhumatoide
CA2391356A1 (en) * 1999-12-21 2001-06-28 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
FR2826124B1 (fr) * 2001-06-13 2004-01-02 Bio Merieux Procede de detection d'auto-anticorps specifiques de la polyarthrite rhumatoide
NL1019540C2 (nl) 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
ES2297521T3 (es) 2003-12-23 2008-05-01 F. Hoffmann-La Roche Ag Metodo para la evaluacion de la artritis reumatoide mediante la medicion de anti-pcc e interleuquina 6.
DK1721162T3 (da) 2004-02-27 2008-12-15 Hoffmann La Roche Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A
JP2010506147A (ja) 2006-09-29 2010-02-25 エフ．ホフマン−ラ ロシュ アーゲー 関節リウマチを有する患者のための疾患進行のリスク評価
EP2336769A1 (de) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Assay zur Unterscheidung zwischen rheumatischen und nicht rheumatischen Leiden
EP3056903A1 (de) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Verfahren zur Beurteilung rheumatoider Arthritis mittels Messung von Anti-CCP und Anti-Casp8
EP3256854A1 (de) 2015-02-13 2017-12-20 F. Hoffmann-La Roche AG Verfahren zur beurteilung von rheumatoider arthritis mittels messung von anti-ccp und anti-pik3cd
EP3056904A1 (de) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Verfahren zur Beurteilung rheumatoider Arthritis mittels Messung von Anti-CCP und Anti-MCM3

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752842B1 (fr) * 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide

Also Published As

Publication number Publication date
WO1999035167A1 (fr) 1999-07-15
EP1042366A1 (de) 2000-10-11
AU1971799A (en) 1999-07-26
FR2773157B1 (fr) 2001-10-05
FR2773157A1 (fr) 1999-07-02

Similar Documents

Publication Publication Date Title
EP0929669B1 (de) Von filaggrin abgeleitete antigene und deren anwendung in der diagnose von rheumatischer polyarthritis
EP0423301B1 (de) Synthetische peptide des konjugates von ubiquitin und histon h2a
EP1814901B1 (de) Von fibrin abgeleitete citrullinpeptide, die durch für rheumatoide arthritis spezifische autoantikörper erkannt werden, und deren verwendung
EP1196450B1 (de) Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis
CA2316269A1 (fr) Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
EP0451070B1 (de) Verfahren zur Identifizierung oder Bestimmung von Proteinen und Verwendungen dazu
EP1204865B1 (de) Synthetische verbindungen mit zwei epitopen für immunoassays
FR2677653A1 (fr) Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune.
CA2204438A1 (fr) Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
EP0491014B1 (de) Peptide von sm-d-antigen, deren benützung zum nachweis von disseminierten lupus-erythemateux
FR2682113A1 (fr) Peptides issus de la proteine a de la ribonucleoproteine snrnp-u1 et leur utilisation pour le diagnostic de la connectivite mixte.
EP1395825B1 (de) Verfahren zum nachweis von rheumatoiden polyarthritis-spezifischen autoantikörpern
EP1423708B1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp
FR2798672A1 (fr) Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic
FR2848566A1 (fr) Peptides epitopiques de l'enzyme thyroperoxydase, les compositions les contenant et leurs applications
FR2908413A1 (fr) Marqueur specifique d'une degradation oxydative de tissus contenant du collagene de type iii,moyens et methodes,kits de diagnostic de suivi ou de pronostic des pathologies ciblees par ce marqueur.
FR2843395A1 (fr) Composition et methodes pour le dosage de l'aa4rp
EP0252787A1 (de) Isolierte und gereinigte Zelloberflächenpolypeptide, erkannt durch die Antikörper, verantwortlich für die Pathogenese von systemischem Lupus erythematosus (SLE), ihre Herstellungsmethode und ihre Verwendung für die Diagnose von SLE
WO2002072628A1 (fr) Polypeptide physiologiquement actif et polynucleotide le codant

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued